Oxycontin maker Purdue Pharma cultivated sympathetic writers and funded think tanks as part of an aggressive media campaign aimed at countering negative stories about its blockbuster opioid, ProPublica reported. For nearly 20 years Purdue followed tactics similar to those of the oil and tobacco industries by promoting science that advanced its agenda and shifting blame, […]


Know more, do more.

You'll get access to all of our original analysis, exclusive features, and more for just $9.